O	1	5	TxA2	TxA2	NN	B-NP
O	5	6	,	,	,	O
O	7	16	generated	generate	VBN	B-VP
O	17	21	from	from	IN	B-PP
O	22	33	arachidonic	arachidonic	JJ	B-NP
O	34	38	acid	acid	NN	I-NP
O	39	41	by	by	IN	B-PP
O	42	56	cyclooxygenase	cyclooxygenase	NN	B-NP
O	57	58	1	1	CD	I-NP
O	59	60	(	(	(	O
O	60	63	COX	COX	NN	B-NP
O	63	64	-	-	HYPH	B-NP
O	64	65	1	1	CD	I-NP
O	65	66	)	)	)	O
O	67	70	and	and	CC	O
O	71	73	Tx	Tx	NN	B-NP
O	74	82	synthase	synthase	NN	I-NP
O	82	83	,	,	,	O
O	84	91	further	further	RBR	B-ADVP
O	92	101	amplifies	amplify	VBZ	B-VP
B-Cell	102	110	platelet	platelet	NN	B-NP
O	111	121	activation	activation	NN	I-NP
O	121	122	.	.	.	O

O	123	126	COX	COX	NN	B-NP
O	126	127	-	-	HYPH	B-NP
O	127	128	1	1	CD	I-NP
O	129	137	converts	convert	VBZ	B-VP
O	138	149	arachidonic	arachidonic	JJ	B-NP
O	150	154	acid	acid	NN	I-NP
O	155	159	into	into	IN	B-PP
O	160	173	prostaglandin	prostaglandin	NN	B-NP
O	174	187	endoperoxides	endoperoxide	VBZ	B-VP
O	188	192	PGG2	PGG2	NN	B-NP
O	193	196	and	and	CC	I-NP
O	197	201	PGH2	PGH2	NN	I-NP
O	201	202	,	,	,	O
O	203	206	the	the	DT	B-NP
O	207	213	latter	latter	JJ	I-NP
O	214	219	being	being	NN	I-NP
O	219	220	,	,	,	O
O	221	223	in	in	IN	B-PP
O	224	228	turn	turn	NN	B-NP
O	228	229	,	,	,	O
O	230	241	transformed	transform	VBN	B-VP
O	242	244	by	by	IN	B-PP
O	245	247	Tx	Tx	NN	B-NP
O	248	256	synthase	synthase	NN	I-NP
O	257	261	into	into	IN	B-PP
O	262	266	TxA2	TxA2	NN	B-NP
O	266	267	,	,	,	O
O	268	269	a	a	DT	B-NP
O	270	276	potent	potent	JJ	I-NP
O	277	286	amplifier	amplifier	NN	I-NP
O	287	289	of	of	IN	B-PP
B-Cell	290	298	platelet	platelet	NN	B-NP
O	299	310	aggregation	aggregation	NN	I-NP
O	311	315	with	with	IN	B-PP
O	316	332	vasoconstrictive	vasoconstrictive	JJ	B-NP
O	333	343	properties	property	NNS	I-NP
O	343	344	.	.	.	O

O	345	347	At	At	IN	B-PP
O	348	351	the	the	DT	B-NP
B-Multi-tissue_structure	352	356	site	site	NN	I-NP
O	357	359	of	of	IN	B-PP
O	360	363	the	the	DT	B-NP
B-Pathological_formation	364	372	atheroma	atheroma	NN	I-NP
O	373	380	rupture	rupture	NN	I-NP
O	380	381	,	,	,	O
B-Cell	382	390	platelet	platelet	NN	B-NP
O	390	391	-	-	HYPH	B-VP
O	391	399	released	release	VBN	B-NP
O	400	404	TxA2	TxA2	NN	I-NP
O	405	410	leads	lead	VBZ	B-VP
O	411	413	to	to	TO	B-PP
O	414	424	downstream	downstream	JJ	B-ADJP
B-Tissue	425	430	micro	micro	AFX	O
I-Tissue	430	431	-	-	HYPH	O
I-Tissue	431	437	vessel	vessel	NN	B-NP
O	438	449	contraction	contraction	NN	I-NP
O	450	453	and	and	CC	O
B-Pathological_formation	454	462	thrombus	thrombus	NN	B-NP
O	463	474	propagation	propagation	NN	I-NP
O	475	476	(	(	(	O
O	476	477	7	7	CD	B-NP
O	477	478	)	)	)	O
O	478	479	.	.	.	O

O	480	482	In	In	IN	B-PP
O	483	491	addition	addition	NN	B-NP
O	492	494	to	to	TO	B-PP
O	495	498	its	its	PRP$	B-NP
O	499	503	role	role	NN	I-NP
O	504	506	in	in	IN	B-PP
O	507	518	coagulation	coagulation	NN	B-NP
O	518	519	,	,	,	O
O	520	528	thrombin	thrombin	NN	B-NP
O	529	531	at	at	IN	B-PP
O	532	541	extremely	extremely	RB	B-NP
O	542	545	low	low	JJ	I-NP
O	546	560	concentrations	concentration	NNS	I-NP
O	561	563	is	be	VBZ	B-VP
O	564	567	one	one	CD	B-NP
O	568	570	of	of	IN	B-PP
O	571	574	the	the	DT	B-NP
O	575	580	major	major	JJ	I-NP
B-Cell	581	589	platelet	platelet	NN	I-NP
O	590	600	activators	activator	NNS	I-NP
O	601	602	(	(	(	O
O	602	603	8	8	CD	B-NP
O	603	604	)	)	)	O
O	604	605	.	.	.	O

O	606	611	Human	Human	JJ	B-NP
B-Cell	612	621	platelets	platelet	NNS	I-NP
O	622	629	express	express	VBP	B-VP
O	630	633	two	two	CD	B-NP
B-Cellular_component	634	638	cell	cell	NN	I-NP
I-Cellular_component	639	646	surface	surface	NN	I-NP
O	647	648	G	G	NN	I-NP
O	648	649	-	-	HYPH	B-NP
O	649	656	protein	protein	NN	I-NP
O	656	657	-	-	HYPH	O
O	657	664	coupled	couple	VBN	B-NP
O	665	673	protease	protease	NN	I-NP
O	673	674	-	-	HYPH	B-NP
O	674	683	activated	activate	VBN	I-NP
O	684	693	receptors	receptor	NNS	I-NP
O	694	695	(	(	(	O
O	695	699	PARs	PAR	NNS	B-NP
O	699	700	)	)	)	O
O	701	704	for	for	IN	B-PP
O	705	713	thrombin	thrombin	NN	B-NP
O	713	714	:	:	:	O
O	715	718	PAR	PAR	NN	B-NP
O	718	719	-	-	HYPH	B-NP
O	719	720	1	1	CD	I-NP
O	721	724	and	and	CC	I-NP
O	725	728	PAR	PAR	NN	I-NP
O	728	729	-	-	:	O
O	729	730	4	4	CD	B-NP
O	730	731	.	.	.	O

O	732	734	By	By	IN	B-PP
O	735	742	binding	bind	VBG	B-VP
O	743	746	the	the	DT	B-NP
O	747	754	hirudin	hirudin	NN	I-NP
O	754	755	-	-	HYPH	B-NP
O	755	759	like	like	JJ	I-NP
B-Immaterial_anatomical_entity	760	773	extracellular	extracellular	JJ	I-NP
O	774	779	amino	amino	NN	I-NP
O	780	788	terminal	terminal	JJ	I-NP
O	789	795	domain	domain	NN	I-NP
O	796	797	(	(	(	O
O	797	800	the	the	DT	B-NP
O	801	803	so	so	RB	I-NP
O	803	804	-	-	HYPH	I-NP
O	804	810	called	call	VBN	I-NP
O	811	819	thrombin	thrombin	NN	I-NP
O	820	828	receptor	receptor	NN	I-NP
O	828	829	)	)	)	O
O	829	830	,	,	,	O
O	831	839	thrombin	thrombin	NN	B-NP
O	840	849	activates	activate	VBZ	B-VP
B-Cell	850	859	platelets	platelet	NNS	B-NP
O	860	863	and	and	CC	O
B-Cell	864	870	smooth	smooth	JJ	B-NP
I-Cell	871	877	muscle	muscle	NN	I-NP
I-Cell	878	883	cells	cell	NNS	I-NP
O	883	884	,	,	,	O
O	885	889	thus	thus	RB	B-ADVP
O	890	899	promoting	promote	VBG	B-VP
B-Cell	900	908	platelet	platelet	NN	B-NP
O	909	912	pro	pro	AFX	O
O	912	913	-	-	HYPH	O
O	913	922	coagulant	coagulant	NN	B-NP
O	923	931	activity	activity	NN	I-NP
O	931	932	,	,	,	O
O	933	938	shape	shape	NN	B-NP
O	939	945	change	change	NN	I-NP
O	945	946	,	,	,	O
O	947	956	secretion	secretion	NN	B-NP
O	957	960	and	and	CC	I-NP
O	961	968	release	release	NN	I-NP
O	969	971	of	of	IN	B-PP
O	972	980	agonists	agonist	NNS	B-NP
O	981	982	(	(	(	O
O	982	985	ADP	ADP	NN	B-NP
O	986	989	and	and	CC	O
O	990	994	TxA2	TxA2	NN	B-NP
O	994	995	)	)	)	O
O	995	996	,	,	,	O
O	997	1007	expression	expression	NN	B-NP
O	1008	1010	of	of	IN	B-PP
O	1011	1012	P	P	NN	B-NP
O	1012	1013	-	-	HYPH	O
O	1013	1021	selectin	selectin	NN	B-NP
O	1021	1022	,	,	,	O
O	1023	1033	activation	activation	NN	B-NP
O	1034	1036	of	of	IN	B-PP
O	1037	1040	the	the	DT	B-NP
O	1041	1054	alphaIIbbeta3	alphaIIbbeta3	NN	I-NP
O	1055	1063	integrin	integrin	NN	I-NP
O	1064	1072	receptor	receptor	NN	I-NP
O	1072	1073	,	,	,	O
O	1074	1077	and	and	CC	O
O	1078	1089	aggregation	aggregation	NN	B-NP
O	1089	1090	.	.	.	O

O	1091	1099	Thrombin	Thrombin	NN	B-NP
O	1100	1104	also	also	RB	B-ADVP
O	1105	1110	binds	bind	VBZ	B-VP
O	1111	1113	to	to	TO	B-PP
O	1114	1123	GpIbalpha	GpIbalpha	NN	B-NP
O	1124	1126	on	on	IN	B-PP
O	1127	1130	the	the	DT	B-NP
B-Cellular_component	1131	1138	surface	surface	NN	I-NP
O	1139	1141	of	of	IN	B-PP
B-Cell	1142	1151	platelets	platelet	NNS	B-NP
O	1151	1152	,	,	,	O
O	1153	1160	thought	think	VBN	B-VP
O	1161	1163	to	to	TO	I-VP
O	1164	1167	act	act	VB	I-VP
O	1168	1170	as	as	IN	B-PP
O	1171	1172	a	a	DT	B-NP
O	1173	1175	co	co	AFX	I-NP
O	1175	1176	-	-	HYPH	I-NP
O	1176	1182	factor	factor	NN	I-NP
O	1183	1187	that	that	WDT	B-NP
O	1188	1197	localizes	localize	VBZ	B-VP
O	1198	1201	the	the	DT	B-NP
O	1202	1208	enzyme	enzyme	NN	I-NP
O	1209	1211	on	on	IN	B-PP
O	1212	1215	the	the	DT	B-NP
B-Cellular_component	1216	1224	platelet	platelet	NN	I-NP
I-Cellular_component	1225	1232	surface	surface	NN	I-NP
O	1233	1236	and	and	CC	O
O	1237	1248	accelerates	accelerate	VBZ	B-VP
O	1249	1252	the	the	DT	B-NP
O	1253	1263	hydrolysis	hydrolysis	NN	I-NP
O	1264	1266	of	of	IN	B-PP
O	1267	1270	PAR	PAR	NN	B-NP
O	1270	1271	-	-	HYPH	B-NP
O	1271	1272	1	1	CD	I-NP
O	1273	1274	(	(	(	O
O	1274	1275	9	9	CD	B-NP
O	1275	1276	)	)	)	O
O	1276	1277	.	.	.	O

O	1278	1281	PAR	PAR	NN	B-NP
O	1281	1282	-	-	HYPH	B-NP
O	1282	1283	1	1	CD	I-NP
O	1284	1287	and	and	CC	I-NP
O	1288	1293	P2Y12	P2Y12	NN	I-NP
O	1294	1299	cross	cross	AFX	O
O	1299	1300	-	-	HYPH	O
O	1300	1305	react	react	NN	B-NP
O	1306	1308	in	in	IN	B-PP
B-Cell	1309	1317	platelet	platelet	NN	B-NP
O	1318	1328	activation	activation	NN	I-NP
O	1328	1329	,	,	,	O
O	1330	1333	and	and	CC	O
O	1334	1341	Galphaq	Galphaq	NNP	B-NP
O	1342	1345	and	and	CC	I-NP
O	1346	1353	Galphai	Galphai	NNP	I-NP
O	1353	1354	-	-	HYPH	B-NP
O	1354	1361	coupled	couple	VBN	I-NP
O	1362	1371	receptors	receptor	NNS	I-NP
O	1372	1375	are	be	VBP	B-VP
O	1376	1384	involved	involve	VBN	I-VP
O	1385	1387	in	in	IN	B-PP
O	1388	1392	this	this	DT	B-NP
O	1393	1400	process	process	NN	I-NP
O	1400	1401	.	.	.	O

O	1402	1410	Thrombin	Thrombin	NN	B-NP
O	1410	1411	-	-	HYPH	I-NP
O	1411	1420	dependent	dependent	JJ	I-NP
B-Cell	1421	1429	platelet	platelet	NN	I-NP
O	1430	1441	aggregation	aggregation	NN	I-NP
O	1442	1444	is	be	VBZ	B-VP
O	1445	1453	mediated	mediate	VBN	I-VP
O	1454	1456	in	in	IN	B-PP
O	1457	1461	part	part	NN	B-NP
O	1462	1464	by	by	IN	B-PP
O	1465	1473	secreted	secrete	VBN	B-NP
O	1474	1477	ADP	ADP	NN	I-NP
O	1477	1478	,	,	,	O
O	1479	1485	acting	act	VBG	B-VP
O	1486	1488	on	on	IN	B-PP
O	1489	1492	the	the	DT	B-NP
O	1493	1500	Galphai	Galphai	NNP	I-NP
O	1500	1501	-	-	HYPH	B-VP
O	1501	1507	linked	link	VBN	B-NP
O	1508	1511	ADP	ADP	NN	I-NP
O	1512	1520	receptor	receptor	NN	I-NP
O	1520	1521	.	.	.	O

O	1522	1524	By	By	IN	B-PP
O	1525	1533	blocking	block	VBG	B-VP
O	1534	1541	Galphaq	Galphaq	NNP	B-NP
O	1542	1545	via	via	IN	B-PP
O	1546	1549	PAR	PAR	NN	B-NP
O	1549	1550	-	-	HYPH	B-NP
O	1550	1551	1	1	CD	I-NP
O	1552	1555	and	and	CC	O
O	1556	1562	Gbetai	Gbetai	NNP	B-NP
O	1563	1566	via	via	IN	B-PP
O	1567	1572	P2Y12	P2Y12	NN	B-NP
O	1572	1573	,	,	,	O
O	1574	1582	combined	combined	JJ	B-NP
O	1583	1593	inhibition	inhibition	NN	I-NP
O	1594	1596	of	of	IN	B-PP
O	1597	1605	thrombin	thrombin	NN	B-NP
O	1606	1609	and	and	CC	I-NP
O	1610	1615	P2Y12	P2Y12	NN	I-NP
O	1616	1625	receptors	receptor	NNS	I-NP
O	1626	1631	leads	lead	VBZ	B-VP
O	1632	1634	to	to	TO	B-PP
O	1635	1636	a	a	DT	B-NP
O	1637	1648	synergistic	synergistic	JJ	I-NP
O	1649	1659	inhibitory	inhibitory	JJ	I-NP
O	1660	1666	effect	effect	NN	I-NP
O	1667	1669	on	on	IN	B-PP
O	1670	1678	thrombin	thrombin	NN	B-NP
O	1678	1679	-	-	HYPH	B-NP
O	1679	1686	induced	induce	VBN	I-NP
B-Cell	1687	1695	platelet	platelet	NN	I-NP
O	1696	1707	aggregation	aggregation	NN	I-NP
O	1708	1709	(	(	(	O
O	1709	1711	10	10	CD	B-NP
O	1711	1712	)	)	)	O
O	1712	1713	.	.	.	O

O	1714	1715	5	5	CD	B-NP
O	1715	1716	-	-	HYPH	I-NP
O	1716	1718	HT	HT	NN	I-NP
O	1719	1721	is	be	VBZ	B-VP
O	1722	1723	a	a	DT	B-NP
O	1724	1739	vasoconstrictor	vasoconstrictor	NN	I-NP
O	1740	1745	agent	agent	NN	I-NP
O	1746	1750	that	that	WDT	B-NP
O	1751	1756	binds	bind	VBZ	B-VP
O	1757	1759	to	to	TO	B-PP
O	1760	1763	5HT	5HT	NN	B-NP
O	1763	1764	-	-	HYPH	I-NP
O	1764	1766	2A	2A	NN	I-NP
O	1767	1776	receptors	receptor	NNS	I-NP
O	1777	1780	and	and	CC	O
O	1781	1790	amplifies	amplify	VBZ	B-VP
O	1791	1794	the	the	DT	B-NP
B-Cell	1795	1803	platelet	platelet	NN	I-NP
O	1804	1812	response	response	NN	I-NP
O	1813	1815	by	by	IN	B-PP
O	1816	1827	stimulating	stimulate	VBG	B-VP
O	1828	1833	shape	shape	NN	B-NP
O	1834	1840	change	change	NN	I-NP
O	1841	1844	and	and	CC	O
O	1845	1854	enhancing	enhance	VBG	B-VP
B-Cell	1855	1863	platelet	platelet	NN	B-NP
O	1864	1875	recruitment	recruitment	NN	I-NP
O	1876	1878	at	at	IN	B-PP
O	1879	1884	sites	site	NNS	B-NP
O	1885	1887	of	of	IN	B-PP
O	1888	1894	injury	injury	NN	B-NP
O	1895	1896	(	(	(	O
O	1896	1897	3	3	CD	B-NP
O	1897	1898	)	)	)	O
O	1898	1899	.	.	.	O

O	1900	1902	It	It	PRP	B-NP
O	1903	1906	may	may	MD	B-VP
O	1907	1911	also	also	RB	I-VP
O	1912	1916	play	play	VB	I-VP
O	1917	1918	a	a	DT	B-NP
O	1919	1922	pro	pro	AFX	I-NP
O	1922	1923	-	-	HYPH	I-NP
O	1923	1932	coagulant	coagulant	JJ	I-NP
O	1933	1937	role	role	NN	I-NP
O	1938	1940	by	by	IN	B-PP
O	1941	1950	promoting	promote	VBG	B-VP
O	1951	1954	the	the	DT	B-NP
O	1955	1964	retention	retention	NN	I-NP
O	1965	1967	of	of	IN	B-PP
O	1968	1978	fibrinogen	fibrinogen	NN	B-NP
O	1979	1982	and	and	CC	I-NP
O	1983	1997	thrombospondin	thrombospondin	NN	I-NP
O	1998	2000	on	on	IN	B-PP
O	2001	2004	the	the	DT	B-NP
B-Cellular_component	2005	2013	platelet	platelet	NN	I-NP
I-Cellular_component	2014	2021	surface	surface	NN	I-NP
O	2021	2022	.	.	.	O

B-Immaterial_anatomical_entity	2023	2036	Intraplatelet	Intraplatelet	NNP	B-NP
O	2037	2038	5	5	CD	I-NP
O	2038	2039	-	-	HYPH	I-NP
O	2039	2041	HT	HT	NN	I-NP
O	2042	2048	stores	store	NNS	I-NP
O	2049	2052	are	be	VBP	B-VP
O	2053	2063	implicated	implicate	VBN	I-VP
O	2064	2066	in	in	IN	B-PP
O	2067	2072	shear	shear	NN	B-NP
O	2072	2073	-	-	HYPH	B-NP
O	2073	2080	induced	induce	VBN	I-NP
B-Cell	2081	2089	platelet	platelet	NN	I-NP
O	2090	2101	aggregation	aggregation	NN	I-NP
O	2102	2105	and	and	CC	O
B-Pathological_formation	2106	2114	thrombus	thrombus	NN	B-NP
O	2115	2126	propagation	propagation	NN	I-NP
O	2127	2128	(	(	(	O
O	2128	2129	3	3	CD	B-NP
O	2129	2130	)	)	)	O
O	2130	2131	.	.	.	O

